Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 28

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 28
---
 sales agent, will
use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal laws, rules
and regulations and the rules of Nasdaq, to sell common stock under the terms and subject to the conditions of the placement notice and
the Sales Agreement. We or A.G.P. may suspend the offering of common stock pursuant to a placement notice upon notice and subject to other
conditions.

Settlement for sales of common
stock, unless the parties agree otherwise, will occur on the first trading day following the date on which any sales are made in return
for payment of the net proceeds to us. There are no arrangements to place any of the proceeds of this offering in an escrow, trust or
similar account. Sales of our common stock as contemplated in this prospectus supplement will be settled through the facilities of The
Depository Trust Company or by such other means as we and A.G.P. may agree upon.

Because there are no minimum
sale requirements as a condition to this offering, the actual total public offering price, commissions and net proceeds to us, if any,
are not determinable at this time. The actual dollar amount and number of common shares we sell through this prospectus supplement will
be dependent, among other things, on market conditions and our capital raising requirements.

We will report at least quarterly
the number of common stock sold through A.G.P. under the Sales Agreement, the net proceeds to us and the compensation paid by us to A.G.P.
in connection with the sales of common stock under the Sales Agreement.

The offering pursuant to
the Sales Agreement will terminate upon the earlier of (i) the sale of all common stock subject to the Sales Agreement and (ii) termination
of the Sales Agreement as permitted therein. We may terminate the Sales Agreement in our sole discretion at any time by giving two days’
prior notice to A.G.P. A.G.P. may terminate the Sales Agreement under the circumstances specified in the sales agreement and in its sole
discretion at any time by giving two days’ prior notice to us.

This prospectus supplement
in electronic format may be made available on a website maintained by A.G.P., and A.G.P. may distribute this prospectus supplement electronically.

Fees and Expenses

We will pay A.G.P.
commissions for its services in acting as our sales agent in the sale of our common stock pursuant to the Sales Agreement. A.G.P.
will be entitled to compensation at a fixed commission rate of 3